We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LABS market cap is 133.7M. The company's latest EPS is GBP -0.0789 and P/E is -4.87.
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Total Revenue | 532k | 15.71M |
Operating Income | -302k | 8.16M |
Net Income | 7.74M | -27.61M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Total Assets | 361.4M | 447.83M |
Total Liabilities | 10.82M | 128.37M |
Total Equity | 350.58M | 319.45M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Operating | 3.54M | -1.09M |
Investing | -181.52M | -186.38M |
Financing | 343.94M | 67.11M |
Market Cap | 133.7M |
Price to Earnings Ratio | -4.87 |
Price to Sales Ratio | 8.55 |
Price to Cash Ratio | 2.95 |
Price to Book Ratio | 0.42 |
Dividend Yield | 10.47% |
Shares Outstanding | 350M |
Average Volume (1 week) | 908.45k |
Average Volume (1 Month) | 839.29k |
52 Week Change | -46.50% |
52 Week High | 77.00 |
52 Week Low | 37.00 |
Spread (Intraday) | 0.2 (0.52%) |
Company Name | Life Science Reit Plc |
Address |
6th floor 65 london EC2V 7NQ |
Website | https://www.lifesciencereit.co.uk |
Industry | real estate investment trust (6798) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions